UBS Lowers PT on Ambev S.A. (ABEV) to $2.20 from $2.50, Keeps a Neutral Rating

Ambev S.A. (NYSE:ABEV) is one of the best stocks under $10 to buy right now. On August 20, UBS analyst Rodrigo Alcantara lowered the firm’s price target on Ambev S.A. (NYSE:ABEV) to $2.20 from $2.50, keeping a Neutral rating on the shares.

The rating update followed Ambev S.A.’s (NYSE:ABEV) fiscal Q2 2025 results on July 31, with net revenue (organic) growth of 3.4% and top-line performance driven by net revenue per hectoliter (NR/hl) growth of 8.4%.

Management reported that normalized profit for the quarter rose 15.2% to R$2.8327 billion compared to R$2.4591 billion in fiscal Q2 2024. This growth was attributed to lower income tax expenses and EBITDA growth, particularly offset by higher net financial results.

Normalized EBITDA (organic) also grew by 7.6% with all of the company’s reporting segments delivering EBITDA growth.

Ambev S.A. (NYSE:ABEV) produces, distributes, and sells beverages. Its offerings include carbonated soft drinks, beer, and other non-alcoholic and non-carbonated products.

The company’s operations are divided into the following geographical segments: Brazil, Central America and the Caribbean (CAC), and Canada.

While we acknowledge the potential of ABEV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.